Dana Culp, NP
Nurse Practitioner · Quincy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 10 years
- Graduated 2016
Offices
1 location · Plumas District Hospital · 40 clinicians in this group
Hospitals listed: Plumas District Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dana Culp’s office at (530) 283-2121 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Plumas District HospitalQuincy, CACritical Access Hospital · Government - Hospital District or Authority · Has an emergency department79% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Plumas District Hospital
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 2 the same, 1 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 16.9 · 29 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 75 cases | None | Jul 2024 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 41.9 · 27 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.7 · 33 cases | None | Jul 2022 – Jun 2025 |
| Room was "always" clean | 85% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 89% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 93% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 86% |
| Doctors "always" listened carefully | 87% |
| Doctors "always" treated them with courtesy and respect | 92% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 80% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 93% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 59% |
| Yes, staff "did" give patients information about possible symptoms | 95% |
Original Medicare doctor bills
$30,023
Medicare paid this office $30,023 for 206 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 192 | $26,084 | $82 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 154 | $2,259 | $12 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $896 | $60 |
Who their Medicare patients are
206 Original Medicare patients in 2024. Average age 73 · Under 65 18% · 85 and older 15% · Women 73% · Also on Medicaid 20% · Health risk score 1.40. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Depression 47% · Diabetes 28% · Coronary heart disease 27% · Chronic kidney disease 27% · Heart failure 19% · Atrial fibrillation 16% · COPD 15% · Cancer 12% · Dementia 8%.
The office billed $138,867, Medicare allowed $47,213 and paid $30,023; for 528 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 206 | 528 | 73 | 1.40 | $138,867 | $30,023 |
| 2023 | 236 | 456 | 72 | 1.55 | $174,773 | $48,051 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 224 | $41,715 | $102 |
| New patient visit (45+ min) | 47 | $6,117 | $130 |
Medicaid work
$43,274 in 2021
Medicaid paid $43,274 for 421 billed services this clinician did in 2021, up to 77 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 323 | $39,354 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; second dose | 41 | $1,640 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 21 | $840 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; first dose | 21 | $840 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 15 | $600 |
| 2021 | 421 | 5 | 77 | $43,274 |
| 2020 | 77 | 1 | 55 | $9,438 |
See the largest Medicaid services in earlier years
2020
| Clinic visit/encounter, all-inclusive | 77 | $9,438 |
Drugs they prescribed that Part D paid
$167,773
Pharmacies billed $167,773 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 68% of their Part D prescriptions (1,109 of 1,634) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 37% of their opioid prescriptions.
1,489 generic and 145 brand-name prescriptions · $167,773 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine | 253 | $69,871 | $276 |
| Belbuca | 41 | $28,915 | $705 |
| Butrans | 23 | $11,076 | $482 |
| Hydrocodone-Acetaminophen | 319 | $9,719 | $30 |
| Buprenorphine-Naloxone | 17 | $4,117 | $242 |
See all 23 drugs
| Buprenorphine | 253 | $69,871 | $276 |
| Belbuca | 41 | $28,915 | $705 |
| Butrans | 23 | $11,076 | $482 |
| Hydrocodone-Acetaminophen | 319 | $9,719 | $30 |
| Buprenorphine-Naloxone | 17 | $4,117 | $242 |
| Oxycodone-Acetaminophen | 109 | $3,829 | $35 |
| Buprenorphine | 123 | $3,813 | $31 |
| Gabapentin | 85 | $2,135 | $25 |
| Oxycodone | 114 | $1,965 | $17 |
| Pregabalin | 68 | $1,672 | $25 |
| Tramadol | 76 | $1,296 | $17 |
| Fentanyl | 11 | $1,294 | $118 |
| Morphine Sulfate Er | 48 | $1,078 | $22 |
| Naloxone | 16 | $949 | $59 |
| Celecoxib | 11 | $691 | $63 |
| Hydromorphone | 43 | $589 | $14 |
| Diclofenac | 11 | $488 | $44 |
| Tizanidine | 32 | $481 | $15 |
| Morphine Sulfate | 11 | $380 | $35 |
| Acetaminophen-Codeine | 17 | $331 | $19 |
| Cyclobenzaprine | 23 | $308 | $13 |
| Baclofen | 22 | $266 | $12 |
| Methadone | 12 | $183 | $15 |
Year by year
| 2024 | 1,634 | 451 | 68% (1,109) | 9% | $167,773 |
| 2023 | 3,785 | 874 | 69% (2,598) | None | $469,695 |
| 2022 | 1,563 | 254 | 4% (59) | 12% | $134,299 |
| 2021 | 758 | 205 | 6% (46) | None | $48,460 |
| 2020 | 12 | None | 0% (0) | None | $568 |
| 2017 | 39 | 16 | None | None | $1,267 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 38 drugs
| Buprenorphine | 384 | $139,963 | $364 |
| Belbuca | 71 | $57,792 | $814 |
| Oxycontin | 61 | $44,757 | $734 |
| Butrans | 36 | $30,380 | $844 |
| Hydrocodone-Acetaminophen | 852 | $28,476 | $33 |
| Oxycodone-Acetaminophen | 308 | $14,205 | $46 |
| Buprenorphine | 197 | $9,980 | $51 |
| Xarelto | 14 | $9,729 | $695 |
| Oxycodone | 299 | $8,119 | $27 |
| Pregabalin | 102 | $6,270 | $61 |
| Fentanyl | 28 | $4,211 | $150 |
| Buprenorphine-Naloxone | 16 | $3,606 | $225 |
| Morphine Sulfate Er | 135 | $3,430 | $25 |
| Hydromorphone | 163 | $3,184 | $20 |
| Butalbital-Acetaminophen-Caffe | 22 | $2,354 | $107 |
| Gabapentin | 85 | $2,218 | $26 |
| Morphine Sulfate | 42 | $1,991 | $47 |
| Tramadol Hcl Er | 14 | $1,514 | $108 |
| Methadone | 49 | $1,017 | $21 |
| Tramadol | 107 | $994 | $9 |
| Duloxetine | 19 | $873 | $46 |
| Tizanidine | 42 | $707 | $17 |
| Baclofen | 23 | $565 | $25 |
| Carisoprodol | 35 | $476 | $14 |
| Atorvastatin | 23 | $438 | $19 |
| Levothyroxine | 23 | $428 | $19 |
| Diclofenac | 12 | $390 | $32 |
| Losartan | 23 | $386 | $17 |
| Amlodipine Besylate | 19 | $322 | $17 |
| Cyclobenzaprine | 29 | $300 | $10 |
| Valsartan | 13 | $254 | $20 |
| Zolpidem | 27 | $208 | $8 |
| Metformin | 21 | $202 | $10 |
| Acetaminophen-Codeine | 20 | $198 | $10 |
| Lisinopril | 20 | $154 | $8 |
| Diazepam | 23 | $142 | $6 |
| Trazodone | 14 | $116 | $8 |
| Lorazepam | 16 | $106 | $7 |
2022: 46 drugs
| Jardiance | 20 | $22,830 | $1,141 |
| Xarelto | 26 | $21,862 | $841 |
| Januvia | 13 | $14,001 | $1,077 |
| Lantus Solostar | 11 | $13,669 | $1,243 |
| Albuterol Sulfate Hfa | 47 | $2,753 | $59 |
| Flovent Hfa | 11 | $2,338 | $213 |
| Hydrocodone-Acetaminophen | 41 | $1,194 | $29 |
| Fenofibrate | 12 | $1,161 | $97 |
| Potassium Chloride | 37 | $1,118 | $30 |
| Valsartan | 33 | $1,051 | $32 |
| Gabapentin | 39 | $899 | $23 |
| Atorvastatin | 76 | $829 | $11 |
| Tamsulosin | 28 | $752 | $27 |
| Levothyroxine | 42 | $743 | $18 |
| Losartan | 49 | $728 | $15 |
| Hydroxyzine | 28 | $716 | $26 |
| Estradiol | 17 | $693 | $41 |
| Metoprolol | 30 | $449 | $15 |
| Amlodipine Besylate | 46 | $400 | $9 |
| Trazodone | 29 | $389 | $13 |
| Fluticasone Propionate | 16 | $375 | $23 |
| Rosuvastatin | 12 | $371 | $31 |
| Pantoprazole | 20 | $371 | $19 |
| Lisinopril | 47 | $347 | $7 |
| Metformin | 43 | $307 | $7 |
| Alendronate | 21 | $273 | $13 |
| Oxybutynin Chloride | 14 | $268 | $19 |
| Omeprazole | 25 | $215 | $9 |
| Lorazepam | 13 | $197 | $15 |
| Losartan-Hydrochlorothiazide | 12 | $192 | $16 |
| Lovastatin | 13 | $188 | $14 |
| Ibuprofen | 27 | $163 | $6 |
| Prednisone | 25 | $159 | $6 |
| Sulfamethoxazole-Trimethoprim | 13 | $155 | $12 |
| Zolpidem | 24 | $155 | $6 |
| Desipramine | 12 | $148 | $12 |
| Paxlovid (Eua) | 14 | $136 | $10 |
| Triamterene-Hydrochlorothiazid | 20 | $134 | $7 |
| Baclofen | 12 | $133 | $11 |
| Hydrochlorothiazide | 34 | $127 | $4 |
| Furosemide | 18 | $117 | $6 |
| Azithromycin | 17 | $115 | $7 |
| Amoxicillin-Clavulanate Potass | 13 | $113 | $9 |
| Tramadol | 13 | $80 | $6 |
| Cephalexin | 12 | $78 | $7 |
| Metformin Hcl Er | 11 | $59 | $5 |
2021: 16 drugs
| Albuterol Sulfate Hfa | 20 | $1,042 | $52 |
| Duloxetine | 11 | $757 | $69 |
| Hydrocodone-Acetaminophen | 31 | $604 | $19 |
| Losartan | 24 | $356 | $15 |
| Atorvastatin | 32 | $340 | $11 |
| Amlodipine Besylate | 32 | $200 | $6 |
| Metoprolol | 13 | $200 | $15 |
| Levothyroxine | 15 | $189 | $13 |
| Lisinopril | 23 | $141 | $6 |
| Triamterene-Hydrochlorothiazid | 12 | $120 | $10 |
| Zolpidem | 15 | $119 | $8 |
| Metformin | 24 | $116 | $5 |
| Alendronate | 11 | $101 | $9 |
| Ibuprofen | 11 | $83 | $8 |
| Hydrochlorothiazide | 17 | $51 | $3 |
| Tramadol | 13 | $39 | $3 |
Money from drug and device companies
$16 in 2025
| 2025 | 1 | 1 | None | $16 |
| 2023 | 1 | 1 | None | $104 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | The Cologuard Plus Collection Kit | $16 | 1 payment
|
See the published payment
| Exact Sciences | Meals · 2025-06-11 | The Cologuard Plus Collection Kit | $16 |
See earlier years (2023)
2023: $104
| Nevro | Senza | $104 | 1 payment
|
Professional record
- NPI
- 1699213967
- Licence
- CA 95006105
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- Po Box 1603, Graeagle, CA, 96103
- NPI first listed
- 2017-02-07
- NPI last updated
- 2026-03-08
- NPI record certified
- 2026-03-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 400 S 4th St Ste 500, Las Vegas, NV, 89101 · 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306 · 1065 Bucks Lake Rd, Quincy, CA, 95971